Discrimination and Tobacco Use in LGBTQ Young Adults

Apr.20.2023
Discrimination and Tobacco Use in LGBTQ Young Adults
Tobacco Control is an international journal that studies the effects of tobacco on health, economy, environment, and society.

Tobacco Control is an international journal aimed at studying the nature and consequences of tobacco use worldwide, including its impact on population health, the economy, the environment, and society. The journal seeks to prevent and control the widespread use of tobacco through promoting public knowledge of tobacco, industry ethics, policy-making, and social activism by the tobacco industry and its allies, playing a positive role in these areas. On December 7, 2022, the journal published a paper entitled "Discrimination, Identity Connectedness and Tobacco Use in a Sample of Sexual and Gender Minority Young Adults".


Source of image: The front page of the December 2022 issue of "Tobacco Control" journal, featuring an article on discrimination, identity affiliation, and smoking behavior among young adults in the LGBTQ community.


The summary of this paper can be translated into standard journalistic English as follows:


Title: Higher Tobacco Use Among Sexual and Gender Minority Populations According to previous research in academia, a widely accepted viewpoint is that sexual and gender minority (SGM) populations have higher smoking rates than heterosexual or cisgender populations. However, there is little research exploring the smoking habits of different racial/ethnic SGM subgroups or the association between SGM-specific discrimination and identity with smoking behavior. A new study in the United States has shown that SGM populations have higher tobacco use rates compared to heterosexual populations. The study also found differences in tobacco use rates among SGM subgroups based on ethnicity and identity.


The research team includes experts and scholars Alex Budenz, Jennifer Gaber, Erik Crankshaw, Andie Malterud, Emily B Peterson, Dana E Wagner, and Emily C Sanders. These individuals come from various organizations, including the Center for Tobacco Products in the Office of Health Communication and Education at the U.S. Food and Drug Administration, the Center for Health Analytics, Media and Policy at RTI International, and the Research Department at Rescue Agency.


Research methodology: This study surveyed 11,313 young American sexual and gender minority (SGM) adults to investigate the associations between different tobacco use methods (including traditional cigarettes, e-cigarettes, cigars, and tobacco powder) and SGM sub-populations, race/ethnicity, SGM-specific discrimination, and identity. Data analysis was conducted using multiple logistic regression models to predict the relationships between SGM sub-populations, race/ethnicity, SGM-specific discrimination, identity, and various tobacco use methods.


Investigation Results: The study revealed that there are differences in tobacco use among sub-groups of the sexual minority population and between different races/ethnicities. Female homosexuals (especially black female homosexuals) are more likely than average to use multiple tobacco products. White bisexuals and female homosexuals have a higher likelihood of smoking cigarettes and e-cigarettes than the average. Severe discrimination is associated with the use of multiple tobacco products, and the more likely SGM groups are to identify with discrimination and tobacco use being positively correlated, the more likely they are to defend their smoking behavior as being reasonable.


Conclusion: This study found differences in tobacco use among SGM subgroups and among different races/ethnicities. Experiencing discrimination may be a risk factor for tobacco use behavior, while a strong sense of SGM identity may provide an explanatory role for certain tobacco use behaviors among gender and sexual minorities and those experiencing specific SGM discrimination. These findings can guide targeted approaches to reach SGM subgroups at higher risk for tobacco use. The researchers call for the development of more comprehensive and precise policies and interventions to eliminate the inequality surrounding this public health issue.


Reference:


Discrimination, Identity Connections, and Tobacco Use Among Sexual and Gender Minority Young Adults: A Study


Related Reading:


【Science】Latest scientific research clarifies the link between nicotine addiction and human identity cognition.


A recent scientific experiment shows that the flavor of nicotine and marijuana-based electronic cigarette products is a factor in attracting more adolescents to try them.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
The Philippines’ Bureau of Internal Revenue is intensifying enforcement against illicit vape and tobacco products ahead of the Christmas shopping season, directing regional and enforcement offices to strengthen monitoring of production sites, warehouses, distribution channels and retail outlets. The BIR destroyed 240,550 illicit vape products in August with an estimated tax liability of about PHP1.53 billion. A nationwide tax-compliance operation in July also inspected 3,590 businesses involved in tobacco and vapor products.
Regulations
Sep.17 by 2Firsts Perspectives
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08